July 2018, VOLUME 142 / ISSUE 1
Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines
Pedro L. Moro, Silvia Perez-Vilar, Paige Lewis, Marthe Bryant-Genevier, Hajime Kamiya, Maria Cano
Pediatrics Jul 2018, 142 (1) e20174171; DOI: 10.1542/peds.2017-4171
Post-marketing surveillance of DTaP vaccines was conducted in VAERS over a 19 year period to assess for possible rare AEs not detected in observational studies… No new or unexpected adverse events were detected. The observed disproportionate reporting for some nonserious vaccination errors calls for better education of vaccine providers on the specific indications for each of the DTaP vaccines.